IL-17: New Insights into Advances from diagnostics to therapeutics of inflammatory diseases

Authors

  • Ume Habiba
  • Muhammad Babar Khawar Applied Molecular Biology and Biomedicine Lab, Department of Zoology, University of ‎Narowal, ‎Narowal, Pakistan.‎
  • Abdullah Muhammad Sohail
  • Ali Afzal
  • Muddasir Hassan Abbasi
  • Nadeem Sheikh
  • Muhammad Ahsan Ashraf
  • Syeda Eisha Hamid
  • Sara Shahzaman

Keywords:

Keywords: Interleukin 17; Psoriasis; Rheumatoid arthritis; Crohn's disease; Quercetin

Abstract

Interleukin 17 (IL-17) is a proinflammatory cytokine having 6 related cytokines. Over the past few years, the roles of IL-17 go beyond not merely activating inflammation but also progression of disease. Evidence is mounting that IL-17 has significant roles in causing and developing various inflammatory diseases. And recently, specific inhibitions of IL-17 have improved in the treatment of these diseases. This review aims to highlight the general trends of these treatments as well as the various diseases related to IL-17 inflammatory actions, and interactions with other cytokines that perform similar functions.

Downloads

Published

2023-09-25

How to Cite

Ume Habiba, Khawar, M. B., Abdullah Muhammad Sohail, Ali Afzal, Muddasir Hassan Abbasi, Nadeem Sheikh, Muhammad Ahsan Ashraf, Syeda Eisha Hamid, & Sara Shahzaman. (2023). IL-17: New Insights into Advances from diagnostics to therapeutics of inflammatory diseases. UCP Journal of Science &Amp; Technology (HEC Recognized-Y Category), 1(1). Retrieved from http://906535.njxy1.group/index.php/ucpjst/article/view/72